Biophage Pharma Inc. Announces its 2007 First Quarter Financial Results
MONTREAL, April 30 /CNW Telbec/ - Biophage Pharma Inc. (TSX: BUG.V), a
high-potential, revenue-driven biotechnology company focused on the
development of an integrated approach for the prevention and control of
bacterial infections, reported today its financial results for its first
quarter ended February 28, 2007.